UB Paderborn / Katalog / Suche / in CDI

Open synovectomy of the ankle joint in young haemophiliacs: mid-term to long- term results of a single-centre series of 32 procedures

Haemophilia : the official journal of the World Federation of Hemophilia, 2015-07, Vol.21 (4), p.e306-e311

2015

Link zum Volltext

Verfügbarkeit prüfen

Long-term follow-up of children with haemophilia - low incidence of infections with central venous access devices

Haemophilia : the official journal of the World Federation of Hemophilia, 2015-07, Vol.21 (4), p.465-468

2015

Link zum Volltext

Verfügbarkeit prüfen

Screening for von Willebrand disease: contribution of an automated assay for von Willebrand factor activity

Haemophilia : the official journal of the World Federation of Hemophilia, 2012-05, Vol.18 (3), p.e158-e163

2012

Link zum Volltext

Verfügbarkeit prüfen

Deaths associated with acquired haemophilia in France from 2000 to 2009: multiple cause analysis for best care strategies

Haemophilia : the official journal of the World Federation of Hemophilia, 2012-05, Vol.18 (3), p.339-344

2012

Link zum Volltext

Verfügbarkeit prüfen

Spontaneous obturator internus muscle haematoma: a new unpublished cause of ilioipelvic pain in haemophilia

Haemophilia : the official journal of the World Federation of Hemophilia, 2013-01, Vol.19 (1), p.157-160

2013

Link zum Volltext

Verfügbarkeit prüfen

Batch recall of French plasma-derived products due to variant Creutzfeldt-Jakob disease risk: the psychological impact on haemophilic patients, changes in their therapeutic demands and behaviour and ethical considerations

Haemophilia : the official journal of the World Federation of Hemophilia, 2015-01, Vol.21 (1), p.27-33

2015

Link zum Volltext

Verfügbarkeit prüfen

Uncomplicated neurosurgical resection of a malignant glioneuronal tumour under haemostatic cover of rFVIIa in a severe haemophilia patient with a high-titre inhibitor: a case report and literature review of rFVIIa use in major surgeries

Haemophilia : the official journal of the World Federation of Hemophilia, 2010-01, Vol.16 (1), p.54-60

2010

Link zum Volltext

Verfügbarkeit prüfen

Intracranial haemorrhages in French haemophilia patients (1991-2001): clinical presentation, management and prognosis factors for death

Haemophilia : the official journal of the World Federation of Hemophilia, 2005-09, Vol.11 (5), p.452-458

2005

Link zum Volltext

Verfügbarkeit prüfen

Successful long‐term replacement therapy with FXIII concentrate (Fibrogammin® P) for severe congenital factor XIII deficiency: a prospective multicentre study

Journal of thrombosis and haemostasis, 2011-06, Vol.9 (6), p.1264-1266

2011

Link zum Volltext

Verfügbarkeit prüfen

Analysis of biological phenotypes from 42 patients with inherited factor VII deficiency: can biological tests predict the bleeding risk?

Haematologica (Roma), 2004-06, Vol.89 (6), p.704

2004

Link zum Volltext

Verfügbarkeit prüfen

European data of a clinical trial with a sucrose formulated recombinant factor VIII in previously treated haemophilia A patients

Haemophilia : the official journal of the World Federation of Hemophilia, 2002-03, Vol.8 (s2), p.10-14

2002

Link zum Volltext

Verfügbarkeit prüfen

Single-dose (270 μg kg−1) recombinant activated factor VII for the treatment and prevention of bleeds in haemophilia A patients with inhibitors: experience from seven European haemophilia centres

Haemophilia : the official journal of the World Federation of Hemophilia, 2009-05, Vol.15 (3), p.760-765

2009

Link zum Volltext

Verfügbarkeit prüfen

Surgical synovectomy of the knee in young haemophiliacs: Long-term results of a monocentric series of 23 patients

Journal of children's orthopaedics, 2010-02, Vol.4 (1), p.33-37

2010

Link zum Volltext

Verfügbarkeit prüfen

Analyses of the FranceCoag cohort support differences in immunogenicity among one plasma-derived and two recombinant factor VIII brands in boys with severe hemophilia A

Haematologica (Roma), 2018-01, Vol.103 (1), p.179

2018

Link zum Volltext

Verfügbarkeit prüfen

Factor VIII inhibitors development following introduction of B‐domain‐deleted recombinant factor VIII in four hemophilia A previously treated patients

Journal of thrombosis and haemostasis, 2003-11, Vol.1 (11), p.2450-2451

2003

Link zum Volltext

Verfügbarkeit prüfen

Factor VIII inhibitors development following introduction of B‐domain‐deleted recombinant factor VIII in four hemophilia A previously treated patients

Journal of thrombosis and haemostasis, 2003-11, Vol.1 (11), p.2445-2446

2003

Link zum Volltext

Verfügbarkeit prüfen

FranceCoag: a 22-year prospective follow-up of the national French cohort of patients with inherited bleeding disorders

European journal of epidemiology, 2019-05, Vol.34 (5), p.521-532

2019

Link zum Volltext

Verfügbarkeit prüfen

Successful long-term replacement therapy with FXIII concentrate (Fibrogammin(®) P) for severe congenital factor XIII deficiency: a prospective multicentre study

Journal of thrombosis and haemostasis, 2011-06, Vol.9 (6), p.1264-1266

2011

Link zum Volltext

Verfügbarkeit prüfen

Prophylactic and therapeutic recombinant factor VIIa administration to patients with Glanzmann's thrombasthenia: results of an international survey

Journal of thrombosis and haemostasis, 2004-07, Vol.2 (7), p.1096-1103

2004

Link zum Volltext

Verfügbarkeit prüfen

Comparison of anti-human and anti-porcine factor VIII inhibitor levels in 63 patients with severe haemophilia A : a french multicentric study

Vox sanguinis, 1993, Vol.64 (4), p.210-214

1993

Link zum Volltext

Verfügbarkeit prüfen

HIV infection in haemophilia--a European cohort

Archives of disease in childhood, 1993-04, Vol.68 (4), p.521-524

1993

Link zum Volltext

Verfügbarkeit prüfen

Early control of HIV-1 infection in long-term nonprogressors followed since diagnosis in the ANRS SEROCO/HEMOCO cohort

Journal of acquired immune deficiency syndromes (1999), 2009-01, Vol.50 (1), p.19

2009

Link zum Volltext

Verfügbarkeit prüfen

Frequent lymphocytes infection by hepatitis B virus in haemophiliacs

British journal of haematology, 1987-02, Vol.65 (2), p.181-185

1987

Link zum Volltext

Verfügbarkeit prüfen

Gale filarienne

Archives de pédiatrie : organe officiel de la Société française de pédiatrie, 2001, Vol.8 (6), p.604-607

2001

Link zum Volltext

Verfügbarkeit prüfen

Long-term survival of HIV-infected patients with haemophilia

Haemophilia : the official journal of the World Federation of Hemophilia, 1995-01, Vol.1 (1), p.33-36

1995

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Open synovectomy of the ankle joint in young haemophiliacs: mid-term to long- term results of a single-centre series of 32 procedures

Long-term follow-up of children with haemophilia - low incidence of infections with central venous access devices

Screening for von Willebrand disease: contribution of an automated assay for von Willebrand factor activity

Deaths associated with acquired haemophilia in France from 2000 to 2009: multiple cause analysis for best care strategies

Spontaneous obturator internus muscle haematoma: a new unpublished cause of ilioipelvic pain in haemophilia

Batch recall of French plasma-derived products due to variant Creutzfeldt-Jakob disease risk: the psychological impact on haemophilic patients, changes in their therapeutic demands and behaviour and ethical considerations

Uncomplicated neurosurgical resection of a malignant glioneuronal tumour under haemostatic cover of rFVIIa in a severe haemophilia patient with a high-titre inhibitor: a case report and literature review of rFVIIa use in major surgeries

Intracranial haemorrhages in French haemophilia patients (1991-2001): clinical presentation, management and prognosis factors for death

Successful long‐term replacement therapy with FXIII concentrate (Fibrogammin® P) for severe congenital factor XIII deficiency: a prospective multicentre study

Analysis of biological phenotypes from 42 patients with inherited factor VII deficiency: can biological tests predict the bleeding risk?

European data of a clinical trial with a sucrose formulated recombinant factor VIII in previously treated haemophilia A patients

Single-dose (270 μg kg−1) recombinant activated factor VII for the treatment and prevention of bleeds in haemophilia A patients with inhibitors: experience from seven European haemophilia centres

Surgical synovectomy of the knee in young haemophiliacs: Long-term results of a monocentric series of 23 patients

Analyses of the FranceCoag cohort support differences in immunogenicity among one plasma-derived and two recombinant factor VIII brands in boys with severe hemophilia A

Factor VIII inhibitors development following introduction of B‐domain‐deleted recombinant factor VIII in four hemophilia A previously treated patients

Factor VIII inhibitors development following introduction of B‐domain‐deleted recombinant factor VIII in four hemophilia A previously treated patients

FranceCoag: a 22-year prospective follow-up of the national French cohort of patients with inherited bleeding disorders

Successful long-term replacement therapy with FXIII concentrate (Fibrogammin(®) P) for severe congenital factor XIII deficiency: a prospective multicentre study

Prophylactic and therapeutic recombinant factor VIIa administration to patients with Glanzmann's thrombasthenia: results of an international survey

Comparison of anti-human and anti-porcine factor VIII inhibitor levels in 63 patients with severe haemophilia A : a french multicentric study

HIV infection in haemophilia--a European cohort

Early control of HIV-1 infection in long-term nonprogressors followed since diagnosis in the ANRS SEROCO/HEMOCO cohort

Frequent lymphocytes infection by hepatitis B virus in haemophiliacs

Gale filarienne

Long-term survival of HIV-infected patients with haemophilia

Suchergebnisse filtern